BackLB PharmaceuticalsCommon Stock Overview

LB PharmaceuticalsCommon Stock Total Liabilities

Latest total liabilities for LBRX: $15M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$14.79M

Peer average / median

Loading

LB PharmaceuticalsCommon Stock Total Liabilities History

Loading

LB PharmaceuticalsCommon Stock vs. peers: Total Liabilities Comparison

Loading

LB PharmaceuticalsCommon Stock Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

LB PharmaceuticalsCommon Stock (LBRX) FAQ

LB PharmaceuticalsCommon Stock (LBRX) currently reports a total liabilities of $15M as of March 2026. Use the charts on this page to explore LB PharmaceuticalsCommon Stock's total liabilities history and peer comparisons.

LB PharmaceuticalsCommon Stock reported $15M in total liabilities as of March 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LB PharmaceuticalsCommon Stock, and consider following LBRX for alerts when major investors trade the stock.

LB PharmaceuticalsCommon Stock is classified in the Healthcare sector. On total liabilities, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LBRX with unrelated industries.